# Left ventricular assist device

Technology · id `cardio:left-ventricular-assist-device` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: LVAD; Left ventricular assist system

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Acute care and long-term living  

## In plain language

A left ventricular assist device (LVAD) is a pump that helps the left ventricle move blood. MeSH describes heart-assist pumps as small, often implantable, with a pumping chamber and a power source that may sit partly or fully outside the body. In the United States the HeartMate 3 system holds premarket approval P160054. Its approval orders state an indication for short-term support (2017) and later for short- and long-term support, including destination therapy (2018), in advanced refractory left ventricular heart failure.

## Technical summary

MeSH descriptor D006353 (Heart-Assist Devices) is a broad match: its scope note says the pumps are for temporarily assisting the heart, which is narrower than durable LVAD support in time, and wider in device type. FDA product code DSQ (Ventricular (Assist) Bypass), class 3, is a broad match: its name does not limit it to the left ventricle or to one system, and the openFDA classification record is read only for its name and class. The approval facts are for one device family, HeartMate 3 (premarket approval P160054; original order 2017-08-23, supplement S008 2018-10-18). The registry entry for MOMENTUM 3 is filed on the implantation page.

## Claims, with the population each applies to

## Context: Patients for whom the US approval orders of the HeartMate 3 Left Ventricular Assist System state an indication: advanced refractory left ventricular heart failure

Recipient: Recipient not specified; Population: Patients with advanced refractory left ventricular heart failure, as the approval order statements describe them. The statements read here do not name an age group.; Care setting: Implanted left ventricular assist system; Geography: United States (premarket approval of the US Food and Drug Administration); Life stage: Not stated in the statements read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory statement)

### The openFDA record of premarket approval P160054 (Abbott Medical) lists approval of the HeartMate 3 Left Ventricular Assist System on 23 August 2017 under product code DSQ. The approval order states the indication as short-term hemodynamic support, such as bridge to transplant or bridge to myocardial recovery, in patients with advanced refractory left ventricular heart failure. Supplement S008, approved on 18 October 2018, states the indication as short- and long-term mechanical circulatory support, such as bridge to transplant or myocardial recovery, or destination therapy, in the same patients.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients with advanced refractory left ventricular heart failure, as the approval order statements describe them. The statements read here do not name an age group.; Care setting: Implanted left ventricular assist system; Geography: United States (premarket approval of the US Food and Drug Administration); Life stage: Not stated in the statements read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory statement)
- Limitations: This claim covers one device family, the HeartMate 3 system approved under P160054 (product code DSQ). It does not cover other implantable pumps. Only two of the 133 openFDA records for P160054 are read, and later supplements may change the wording. A search listing also showed a 2020 labeling update on pediatric uses and a 2022 update to the instructions for use; neither was read. An FDA approval is a decision about a device, not a finding about how well it works. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.
- Last checked: 2026-11-08
- Sources:
  1. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].pma\_number. Retrieved 2026-11-08T20:41:28Z. Source state: Current. Version fingerprint: 51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60.
     How it applies: Quoted at this locator.
  2. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].applicant. Retrieved 2026-11-08T20:41:28Z. Source state: Current. Version fingerprint: 51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60.
     How it applies: Quoted at this locator.
  3. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].trade\_name. Retrieved 2026-11-08T20:41:28Z. Source state: Current. Version fingerprint: 51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60.
     How it applies: Quoted at this locator.
  4. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].decision\_date. Retrieved 2026-11-08T20:41:28Z. Source state: Current. Version fingerprint: 51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60.
     How it applies: Quoted at this locator.
  5. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].decision\_code. Retrieved 2026-11-08T20:41:28Z. Source state: Current. Version fingerprint: 51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60.
     How it applies: Quoted at this locator.
  6. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].product\_code. Retrieved 2026-11-08T20:41:28Z. Source state: Current. Version fingerprint: 51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60.
     How it applies: Quoted at this locator.
  7. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].ao\_statement, fragment 1 of 2. Retrieved 2026-11-08T20:41:28Z. Source state: Current. Version fingerprint: 51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60.
     How it applies: Quoted at this locator.
  8. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].ao\_statement, fragment 2 of 2. Retrieved 2026-11-08T20:41:28Z. Source state: Current. Version fingerprint: 51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60.
     How it applies: Quoted at this locator.
  9. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].supplement\_number. Retrieved 2026-11-08T20:41:29Z. Source state: Current. Version fingerprint: 76e473079df9a05275390fde81870ba2bce782dddc37138185651f8ca6c1792b.
     How it applies: Quoted at this locator.
  10. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].decision\_date. Retrieved 2026-11-08T20:41:29Z. Source state: Current. Version fingerprint: 76e473079df9a05275390fde81870ba2bce782dddc37138185651f8ca6c1792b.
     How it applies: Quoted at this locator.
  11. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].ao\_statement, fragment 1 of 2. Retrieved 2026-11-08T20:41:29Z. Source state: Current. Version fingerprint: 76e473079df9a05275390fde81870ba2bce782dddc37138185651f8ca6c1792b.
     How it applies: Quoted at this locator.
  12. Supports: FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008) (Regulator, edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read.) <https://api.fda.gov/device/pma.json?search=pma_number:P160054&sort=decision_date:asc&limit=1>
     Locator: results\[0\].ao\_statement, fragment 2 of 2. Retrieved 2026-11-08T20:41:29Z. Source state: Current. Version fingerprint: 76e473079df9a05275390fde81870ba2bce782dddc37138185651f8ca6c1792b.
     How it applies: Quoted at this locator.

## Connected pages

- US approval orders for HeartMate 3 state support in advanced refractory left ventricular heart failure: Heart failure (`cardio:heart-failure`) [a claim, not a settled fact; see claim `cardio:claim-fda-heartmate-3-indications` and its context]
- The temporary-support page covers short-term pumps; durable pumps are on this page: Temporary mechanical circulatory support (heart pumps) (`cardio:mechanical-circulatory-support`)
- Filed under this front: Devices and monitoring (`cardio:front-devices-and-monitoring`)
- Related to: Heart transplantation (`cardio:heart-transplantation`)
- Used by: Left ventricular assist device (LVAD) implantation (`cardio:left-ventricular-assist-device-lvad-implantation`)

## Provenance

Content hash: 05cb18dd5f8a5e0541641e133f1972530d26032820610acb8d0470d6c9eb06e8
Last substantive edit: 2026-11-08
Evidence last checked: 2026-11-08
